Can’t Stop Buying This Dividend Juggernaut: ABBV Growth
A long-time investor explains why AbbVie’s mix of rapidly growing immunology drugs and a dependable dividend keeps dr...
This page offers a quick comparison of Index Fund and Target Date for retirement, with tips on matching your plans and risk tolerance.
24,517 articlesA long-time investor explains why AbbVie’s mix of rapidly growing immunology drugs and a dependable dividend keeps dr...
South Korea’s Bitplanet signs a strategic agreement with Nasdaq-listed Antalpha to mine Bitcoin using KRW 15 billion ...
IBM unveils a groundbreaking 0.7nm nanostack in a research setting, reiterating it will not become a chipmaker. The m...
In a crowded crypto landscape, Ethereum still stands out for three core reasons. From its mature smart contract ecosy...
Moderna led a broad vaccine stock rally, rising about 14% as investors priced in pipeline momentum and favorable regu...
Harmony Gold Mining Stock slid about 12% over the week as gold prices cooled and rate expectations shifted. This arti...
A single quarterly beat isn’t the whole story. Micron’s latest results point to a multi-decade growth thesis that goe...
A new open-source coalition backed by Mozilla is mobilizing policymakers and investors to curb Big Tech’s control ove...
Rivian ranks at the bottom of the JD Power 2026 Initial Quality Study, recording 246 problems per 100 vehicles in the...
Europe endures a blistering heatwave as the U.S. relies on widespread air conditioning. A climate tech executive outl...
A Rotterdam court faces a dramatic move as prosecutors seek bankrupt status for the Knaken exchange after user funds ...
Comcast weighs splitting NBCUniversal from its cable and broadband unit to unlock value. History shows media spinoffs...